<DOC>
	<DOC>NCT00699309</DOC>
	<brief_summary>The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.</brief_summary>
	<brief_title>A Clinical Investigation of the Taperloc® Microplasty™ Hip System</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis Rheumatoid arthritis. Correction of functional deformity. Treatment of nonunion, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. Revision of previously failed femoral head resurfacing component Absolute contraindications include: infection, sepsis, and osteomyelitis. Relative contraindications include: uncooperative patient or patient with neurologic disorders who are incapable of following directions, osteoporosis, metabolic disorders which may impair bone formation, osteomalacia, distant foci of infections which may spread to the implant site, rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, vascular insufficiency, muscular atrophy, or neuromuscular disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Total Hip Replacement</keyword>
	<keyword>Total Hip Arthroplasty</keyword>
	<keyword>Minimally Invasive</keyword>
	<keyword>Microplasty</keyword>
	<keyword>Hip Arthritis</keyword>
</DOC>